Lifecore Biomedical, Inc. (LFCR) Company Gross Revenue

Corporate emblem and logo of Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical (LFCR) operates as a CDMO provider for the production of injectables and hyaluronic acid, leveraging long-term B2B contracts. The company's sales dynamics confirm this growth, with 0.00 representing the current level of this metric. Integration into the supply chains of industry behemoths makes the company a key link in biomanufacturing, while strict FDA line certification ensures a stable client flow without partner churn.

LFCR - Lifecore Biomedical, Inc. Revenue and Sales Volume over the range 04/28/2023 - 11/13/2026

Comprehensive metric breakdowns and analytics for Lifecore Biomedical Inc. (LFCR)

- share price and consensus valuation forecast:
Price Lifecore|LFCR - Price Target Chart
- market capitalization details:
Market Capitalization Lifecore Biomedical, Inc.|LFCR - Total Company Value
- book capitalization data:
Net Assets per Single Share Lifecore Biomedical|LFCR - Book Capitalization|Market Capitalization to Book Value lifecore.com|LFCR - Company Total Assets
- company liabilities and liquidity data:
Aggregate Debt to Equity Lifecore Biomedical|LFCR - Long-Term Debt to Capital|Current Liabilities to Capital Lifecore|LFCR - Company Aggregate Debts|Debt to Book Value Lifecore Biomedical, Inc.|LFCR - Company Long-Term Debt|Short-Term Debt Lifecore Biomedical|Intermediate Coverage Ratio lifecore.com
- earnings and market ratios statistics:
LFCR - Net Profit|Expected Net Profit Lifecore Biomedical|LFCR - Price to Earnings Ratio|Future Price to Earnings Multiple Lifecore|LFCR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lifecore Biomedical, Inc.|LFCR - Operating profit EBITDA|Net earnings per share for the last four quarters Lifecore Biomedical|LFCR - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months lifecore.com|LFCR - Earnings per share growth in current year|Expected earnings per share growth for next year Lifecore Biomedical
- company sales and revenue statistics:
LFCR - Revenue and Sales Volume|Company Expected Sales Volume Lifecore|LFCR - P/S Multiple|Market Cap to Projected Revenue Lifecore Biomedical, Inc.
Summary company analysis:LFCR lifecore.com
Manufactured products of Lifecore Biomedical, Inc.

Conservative capital demands absolute cash flow transparency to assess business sustainability. This indicator tracks daily inflows from product sales, allowing investors to filter out market noise from the actual trend. For Lifecore Biomedical (LFCR), this is critical due to the risks of losing major CDMO orders and a high debt load. Revenue dynamics reveal whether operational activity is stagnating or growing. By analyzing the company's sales volume, an investor determines the risk of asset freezes.

Analysis of competing companies

IQV (Quintiles) - Company Total Sales|Company Revenue Labcorp Holdings Inc. (LH)|Company Gross Revenue medpace.com|Company Revenue ICON Public Limited Company ICLR|Charles River Laboratories International, Inc. - Company Revenue|Evotec Corp - Revenue and Sales Volume|Company Gross Revenue Fortrea Clinical FTRE|OABI: Revenue and Sales Volume|Company Annual Revenue NOTV (inotivco.com)|CDMO (Avid Bioservices) - Revenue and Sales Volume|Company Total Revenue Catalent Inc. CTLT|Revenue and Sales Volume SCPX